Suppression of UBE2T also inhibits gastric tumor invasion and metastasis via the WNT signal pathway by inhibiting WNT5A and WNT7B, which in turn promotes GSK3B expression, activates β-Catenin, and inhibits the key oncogene c-Myc. The gene discussed is UBE2T; the disease is gastric neoplasm.